| Primary |
| Parkinson's Disease |
35.9% |
| Parkinsonism |
8.2% |
| Hyperprolactinaemia |
7.4% |
| Blood Prolactin Increased |
6.9% |
| Hypertension |
5.0% |
| Depression |
4.6% |
| Pituitary Tumour Benign |
3.6% |
| Acromegaly |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Lactation Inhibition Therapy |
2.9% |
| Prolactinoma |
2.9% |
| Neuroleptic Malignant Syndrome |
2.3% |
| Suppressed Lactation |
2.3% |
| Constipation |
2.1% |
| Pituitary Tumour |
2.1% |
| Menopause |
1.9% |
| Bipolar Disorder |
1.5% |
| Gastritis |
1.5% |
| Blood Prolactin Abnormal |
1.3% |
| Blood Prolactin Decreased |
1.3% |
|
| Vomiting |
19.2% |
| Drug Exposure During Pregnancy |
7.5% |
| Pathological Gambling |
6.8% |
| Tremor |
6.8% |
| Surgery |
6.2% |
| Weight Increased |
6.2% |
| Neuroleptic Malignant Syndrome |
5.5% |
| Nausea |
4.1% |
| Syncope |
4.1% |
| Vision Blurred |
4.1% |
| Weight Decreased |
4.1% |
| Pyrexia |
3.4% |
| Compulsive Shopping |
2.7% |
| Interstitial Lung Disease |
2.7% |
| Normal Newborn |
2.7% |
| Persecutory Delusion |
2.7% |
| Pneumonia |
2.7% |
| Prolactinoma |
2.7% |
| Renal Impairment |
2.7% |
| Sudden Onset Of Sleep |
2.7% |
|
| Secondary |
| Parkinson's Disease |
51.8% |
| Parkinsonism |
7.1% |
| Product Used For Unknown Indication |
5.2% |
| Acromegaly |
4.3% |
| Constipation |
4.0% |
| Blood Prolactin Increased |
3.5% |
| Depression |
3.1% |
| Hypertension |
2.6% |
| Insomnia |
2.6% |
| Neuroleptic Malignant Syndrome |
2.4% |
| Brain Neoplasm |
1.9% |
| Pituitary Tumour |
1.7% |
| Iron Deficiency Anaemia |
1.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.4% |
| Adenoma Benign |
1.2% |
| Cardiac Failure |
1.2% |
| Hypokalaemia |
1.2% |
| Pain |
1.2% |
| Pituitary Tumour Benign |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
|
| Pathological Gambling |
19.2% |
| Abnormal Behaviour |
7.7% |
| Tremor |
7.7% |
| Phobia |
6.7% |
| Drug Dispensing Error |
5.8% |
| Pyrexia |
5.8% |
| Neuroleptic Malignant Syndrome |
4.8% |
| Persecutory Delusion |
4.8% |
| Vomiting |
4.8% |
| Compulsive Shopping |
3.8% |
| Hypokalaemia |
3.8% |
| Optic Nerve Disorder |
3.8% |
| Weight Increased |
3.8% |
| Drug Exposure During Pregnancy |
2.9% |
| Osteoarthritis |
2.9% |
| Pleural Effusion |
2.9% |
| Weight Decreased |
2.9% |
| Blood Growth Hormone Increased |
1.9% |
| Dehydration |
1.9% |
| Escherichia Urinary Tract Infection |
1.9% |
|
| Concomitant |
| Parkinson's Disease |
26.2% |
| Product Used For Unknown Indication |
25.9% |
| Depression |
4.8% |
| Drug Use For Unknown Indication |
3.9% |
| Insomnia |
3.9% |
| Acromegaly |
3.6% |
| Diabetes Mellitus |
3.1% |
| Hypertension |
3.1% |
| Pain |
2.9% |
| Hormone Replacement Therapy |
2.7% |
| Osteoporosis |
2.6% |
| Constipation |
2.4% |
| Drug Exposure During Pregnancy |
2.4% |
| Agitation |
2.1% |
| Hypopituitarism |
2.1% |
| Schizophrenia |
2.1% |
| Hyperprolactinaemia |
1.9% |
| Anxiety |
1.5% |
| Galactosaemia |
1.4% |
| Hypogonadism |
1.4% |
|
| Pyrexia |
14.6% |
| Vomiting |
7.9% |
| Pituitary Tumour Benign |
6.7% |
| Weight Increased |
6.7% |
| Pulmonary Embolism |
5.6% |
| Vaginal Infection |
5.6% |
| White Blood Cell Count Increased |
5.6% |
| Dyskinesia |
4.5% |
| Type 2 Diabetes Mellitus |
4.5% |
| Wheezing |
4.5% |
| Aplasia Pure Red Cell |
3.4% |
| Cardiac Valve Disease |
3.4% |
| Neuroleptic Malignant Syndrome |
3.4% |
| Parkinson's Disease |
3.4% |
| Pneumonia |
3.4% |
| Restlessness |
3.4% |
| Stomach Discomfort |
3.4% |
| Toxicity To Various Agents |
3.4% |
| Vertigo |
3.4% |
| Vision Blurred |
3.4% |
|
| Interacting |
| Parkinson's Disease |
100.0% |
|
|
